批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
>>>原始批准或临时批准<<<
| 审批日期 | 提交号 | 审批结论 | 提交分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
| 2001/10/03 |
ORIG-1(原始申请) |
Approval |
Type 1 - New Molecular Entity |
STANDARD
|
|
|
>>>补充申请<<<
| 审批日期 | 提交号 | 审批结论 | 补充类别或审批类型 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
| 2024/05/31 |
SUPPL-41(补充) |
Approval |
Labeling-Patient Package Insert,Labeling-Package Insert |
STANDARD
|
|
|
| 2022/04/29 |
SUPPL-40(补充) |
Approval |
Labeling-Package Insert,Labeling-Patient Package Insert |
STANDARD
|
|
|
| 2019/05/08 |
SUPPL-37(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2018/12/04 |
SUPPL-36(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2018/12/04 |
SUPPL-35(补充) |
Approval |
Labeling-Package Insert,Labeling-Patient Package Insert |
STANDARD
|
|
|
| 2018/02/12 |
SUPPL-31(补充) |
Approval |
Labeling-Patient Package Insert,Labeling-Package Insert |
STANDARD
|
|
|
| 2017/12/04 |
SUPPL-34(补充) |
Approval |
Labeling-Container/Carton Labels |
STANDARD
|
|
|
| 2017/08/09 |
SUPPL-32(补充) |
Approval |
Labeling-Patient Package Insert,Labeling-Package Insert |
STANDARD
|
|
|
| 2017/05/30 |
SUPPL-28(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2016/09/30 |
SUPPL-27(补充) |
Approval |
Efficacy-Labeling Change With Clinical Data |
STANDARD
|
|
|
| 2016/02/19 |
SUPPL-20(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
| 2014/10/31 |
SUPPL-25(补充) |
Approval |
Labeling-Patient Package Insert |
STANDARD
|
|
|
| 2014/06/18 |
SUPPL-24(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2013/10/04 |
SUPPL-22(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2013/10/04 |
SUPPL-21(补充) |
Approval |
Efficacy-Labeling Change With Clinical Data |
STANDARD
|
|
|
| 2013/07/19 |
SUPPL-23(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
| 2008/04/29 |
SUPPL-18(补充) |
Approval |
Labeling |
STANDARD
|
|
|
| 2007/10/02 |
SUPPL-17(补充) |
Approval |
Labeling |
STANDARD
|
|
|
| 2006/12/12 |
SUPPL-16(补充) |
Approval |
Labeling-Container/Carton Labels |
N/A
|
|
|
| 2005/07/29 |
SUPPL-12(补充) |
Approval |
Efficacy-Labeling Change With Clinical Data |
UNKNOWN
|
|
|
| 2004/03/02 |
SUPPL-8(补充) |
Approval |
Labeling |
STANDARD
|
|
|
| 2004/02/04 |
SUPPL-7(补充) |
Approval |
Labeling |
STANDARD
|
|
|
| 2002/11/05 |
SUPPL-5(补充) |
Approval |
Manufacturing (CMC)-Control |
STANDARD
|
|
|
| 2002/05/29 |
SUPPL-2(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
| 2002/03/27 |
SUPPL-1(补充) |
Approval |
Manufacturing (CMC)-Control |
STANDARD
|
|
|
| 2002/02/05 |
SUPPL-3(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
| 关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
| 001 |
5989581 |
2018/04/08 |
|
|
|
|
|
PDF格式 | **本条是由Drugfuture回溯的历史信息** |
与本品治疗等效的药品
>>>活性成分:ETHINYL ESTRADIOL; ETONOGESTREL; 剂型/给药途径:RING;VAGINAL; 规格:0.015MG/24HR;0.12MG/24HR; 治疗等效代码:AB<<<
| 申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
| 021187 |
001 |
NDA |
NUVARING |
ETHINYL ESTRADIOL; ETONOGESTREL |
RING;VAGINAL |
0.015MG/24HR;0.12MG/24HR |
Prescription |
Yes |
Yes |
AB |
2001/10/03
|
ORGANON USA ORGANON |
| 210830 |
001 |
ANDA |
ELURYNG |
ETHINYL ESTRADIOL; ETONOGESTREL |
RING;VAGINAL |
0.015MG/24HR;0.12MG/24HR |
Prescription |
No |
No |
AB |
2019/12/11
|
AMNEAL |
| 204305 |
001 |
ANDA |
ETHINYL ESTRADIOL; ETONOGESTREL |
ETHINYL ESTRADIOL; ETONOGESTREL |
RING;VAGINAL |
0.015MG/24HR;0.12MG/24HR |
Prescription |
No |
No |
AB |
2021/01/13
|
TEVA PHARMS USA INC |
| 207577 |
001 |
ANDA |
VERARING |
ETHINYL ESTRADIOL; ETONOGESTREL |
RING;VAGINAL |
0.015MG/24HR;0.12MG/24HR |
Discontinued |
No |
No |
AB |
2021/12/09
|
DR REDDYS LABS SA |
| 211328 |
001 |
ANDA |
HALOETTE |
ETHINYL ESTRADIOL; ETONOGESTREL |
RING;VAGINAL |
0.015MG/24HR;0.12MG/24HR |
Prescription |
No |
No |
AB |
2022/08/05
|
DR REDDYS LABS SA |
| 211157 |
001 |
ANDA |
ENILLORING |
ETHINYL ESTRADIOL; ETONOGESTREL |
RING;VAGINAL |
0.015MG/24HR;0.12MG/24HR |
Prescription |
No |
No |
AB |
2023/06/29
|
XIROMED |